Bernhard Reich1, Werner Benzer2, Hanns Harpf3, Peter Hofmann4, Karl Mayr5, Helmuth Ocenasek5, Andrea Podolsky6, Rochus Pokan7, Michael Porodko8, Christoph Puelacher9, Mahdi Sareban1, Heimo Traninger3, Wolfgang Ziegelmeyer10, Josef Niebauer1. 1. Institute of Sports Medicine, Prevention and Rehabilitation Research Institute of Molecular Sports Medicine and Rehabilitation, Paracelsus Medical University Salzburg, Salzburg, Austria. 2. Out-Patient Cardiac Rehabilitation Centre, Feldkirch, Austria. 3. Out-Patient Cardiac Rehabilitation Center, Graz, Austria. 4. Exercise Physiology, Training and Training Therapy Research Group, Institute of Sports Science, University of Graz, Graz, Austria. 5. CARDIOMED Cardiac Rehabilitation Center, Linz, Austria. 6. Institute of Preventive and Applied Sports Medicine, University Hospital Krems, Krems, Austria. 7. Institute of Sport Science, Center for Sport Science and University Sports, University of Vienna, Vienna, Austria. 8. Institute of Preventive and Rehabilitative Medicine, CardioVitals Wels, Wels, Austria. 9. Institute of Out-Patient Cardiac and Pulmonary Rehabilitation, REHAmed-Tirol, Innsbruck, Austria. 10. Out-Patient Cardiac Rehabilitation Center, Steyr, Austria.
Abstract
AIM: Cardiac rehabilitation (CR) is a key component of the treatment of cardiac diseases. The Austrian outpatient CR model is unique, as it provides patients with an extended professionally supervised, multidisciplinary program of 4-6 weeks of phase II (OUT-II) and 6-12 months of phase III (OUT-III) CR. The aim of this analysis was to assess the efficacy of the Austrian outpatient CR model using a nationwide registry. METHODS: Data of all consecutive patients (N = 7560) who completed OUT-II and/or OUT-III between 1 January 2005 and 31 December 2015 were entered prospectively into a registry. OUT-III patients were analyzed separately according to whether the preceding phase II was performed as outpatient (OUT-II/OUT-III, N = 2403) or in-patient (IN-II/OUT-III, N = 2789). All patients underwent assessment of anthropometry, resting blood pressure, lipid profile, fasting blood glucose, exercise capacity, quality of life, anxiety and depression. RESULTS: During OUT-II, patients significantly improved their metabolic risk factor profile and increased exercise capacity by 14.3%. OUT-II/OUT-III patients achieved an additional increase in exercise capacity by 10%, further improvement in high-density lipoprotein (HDL) and stabilization of the remaining risk factors. IN-II/OUT-III patients increased their maximal exercise capacity by 18.4% and there was improvement in blood pressure, HDL, low-density lipoprotein and glucose levels. CONCLUSION: Extended, professionally supervised, multidisciplinary outpatient CR in a large nationwide registry of consecutive patients consistently improved maximal exercise capacity and relevant modifiable cardiovascular risk factors beyond effects seen after IN- or OUT-II alone.
AIM: Cardiac rehabilitation (CR) is a key component of the treatment of cardiac diseases. The Austrian outpatient CR model is unique, as it provides patients with an extended professionally supervised, multidisciplinary program of 4-6 weeks of phase II (OUT-II) and 6-12 months of phase III (OUT-III) CR. The aim of this analysis was to assess the efficacy of the Austrian outpatient CR model using a nationwide registry. METHODS: Data of all consecutive patients (N = 7560) who completed OUT-II and/or OUT-III between 1 January 2005 and 31 December 2015 were entered prospectively into a registry. OUT-III patients were analyzed separately according to whether the preceding phase II was performed as outpatient (OUT-II/OUT-III, N = 2403) or in-patient (IN-II/OUT-III, N = 2789). All patients underwent assessment of anthropometry, resting blood pressure, lipid profile, fasting blood glucose, exercise capacity, quality of life, anxiety and depression. RESULTS: During OUT-II, patients significantly improved their metabolic risk factor profile and increased exercise capacity by 14.3%. OUT-II/OUT-III patients achieved an additional increase in exercise capacity by 10%, further improvement in high-density lipoprotein (HDL) and stabilization of the remaining risk factors. IN-II/OUT-III patients increased their maximal exercise capacity by 18.4% and there was improvement in blood pressure, HDL, low-density lipoprotein and glucose levels. CONCLUSION: Extended, professionally supervised, multidisciplinary outpatient CR in a large nationwide registry of consecutive patients consistently improved maximal exercise capacity and relevant modifiable cardiovascular risk factors beyond effects seen after IN- or OUT-II alone.
Authors: Stefan Tino Kulnik; Mahdi Sareban; Isabel Höppchen; Silke Droese; Andreas Egger; Johanna Gutenberg; Barbara Mayr; Bernhard Reich; Daniela Wurhofer; Josef Niebauer Journal: Front Psychol Date: 2022-02-15
Authors: Jacek Hincz; Maciej Sterliński; Dariusz Kostrzewa; Rafał Dąbrowski; Edyta Smolis-Bąk Journal: Int J Environ Res Public Health Date: 2022-09-02 Impact factor: 4.614
Authors: Kelly L Wierenga; David M Fresco; Megan Alder; Abdus Sattar; Shirley M Moore Journal: J Cardiovasc Nurs Date: 2022 May-Jun 01 Impact factor: 2.468